1. van Hecke, O., Austin, S. K., Khan, R. A., Smith, B. H. & Torrance, N. Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain 155, 654–662, doi:S0304-3959(13)00610-6 (2014).
2. Latremoliere, A. & Woolf, C. J. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain 10, 895–926, https://doi.org/10.1016/j.jpain.2009.06.012 (2009).
3. Gwak, Y. S. & Hulsebosch, C. E. Neuronal hyperexcitability: a substrate for central neuropathic pain after spinal cord injury. Current pain and headache reports 15, 215–222, https://doi.org/10.1007/s11916-011-0186-2 (2011).
4. Bialer, M. Why are antiepileptic drugs used for nonepileptic conditions? Epilepsia 53(Suppl 7), 26–33, https://doi.org/10.1111/j.1528-1167.2012.03712.x (2012).
5. Eisenberg, E., McNicol, E. D. & Carr, D. B. Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: systematic review and meta-analysis of randomized controlled trials. JAMA 293, 3043–3052, doi:293/24/3043 (2005).